We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ondine Biomedical Inc. | LSE:OBI | London | Ordinary Share | CA68234M2058 | COM SHS NPV (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.75 | -9.68% | 7.00 | 7.00 | 8.00 | 7.75 | 7.50 | 7.75 | 80,025 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 638k | -19.37M | -0.0996 | -0.75 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/5/2024 09:20 | Have you bought any jet Jailbird..I've only bought a token commitment for now. | marvelman | |
03/5/2024 09:17 | We keep thinking one more funding will do it , then they mention another will be needed .Would expect the strike price to be higher though next time | jailbird | |
03/5/2024 09:12 | these will bag and some on phase 3 funding completion which is near term nows the time to get in gl | purple11 | |
03/5/2024 09:10 | I want this company to succeed for the groundbreaking product. However, investors may be waiting a long time for it to reach profitability. A further fundraising has been indicated and with these things there might yet be several more as the company does smaller placements along the way. I'm interested but will wait it out as the risks are still high and the US P3 results once funding is obtained might be 18 months to 24 months away. | hj996 | |
03/5/2024 09:08 | When we get further news regarding the phase 3 trials that's when the share price will really take off. From the latest rns: The net proceeds of the Fundraising will be used for general working capital, US Phase 3 Clinical Trial readiness and start-up preparation, and to support the Company's rapid sales growth of its Steriwave® nasal decolonisation therapy. | z1co | |
03/5/2024 08:53 | Not sure why it uses so much cash , with potential further cash needed this year Excluding the Phase 3 clinical trial execution and related costs which are subject to further funding, the net proceeds of the Fundraising and strategic cost management will provide runway for the Company through to at least mid Q3 2024. This may be further extended through the issue of further New Common Shares in connection with future fundraisings, and/or the attainment of a higher value of commercial sales than is currently forecast. | jailbird | |
03/5/2024 08:51 | purple113 May '24 - 08:06 - 327 of 327(premium) 0 0 2 in@5.50p gla ==================== You're so pathetic no trades at 5.50p ,all trades are at 6p or above. | z1co | |
03/5/2024 08:47 | Surprised at the muted reaction given the premium on the placing. Nevertheless its what we have been waiting for so its worth taking a chance now. | marvelman | |
03/5/2024 08:41 | Great news , time to buy and hold for longer term now Did anyone last nights RNS? Owners had inject cash before raise | jailbird | |
03/5/2024 08:16 | Discussions are underway with HCA Healthcare's investment arm, Health Insight Capital, for its funding support of the key Phase 3 clinical trial. The Company is confident in its ability to secure longer-term financing to execute its growth opportunities. The Company has received an indication of further support from its founder, CEO and substantial shareholder, Carolyn Cross, to provide additional near-term funding to extend the Company's runway should that be required prior to arranging funding for the Phase 3 clinical trial and working capital. | purple11 | |
03/5/2024 08:13 | Carolyn Cross, CEO of Ondine, said: "We are pleased to have the support of existing and new investors through this fundraising which meets our near-term working capital needs and assists our rapid commercial growth rate. This funding will take us forward commercially and further our discussions with industry partners on our clinical, financial, and global distribution objectives. We believe that our product, Steriwave, is very well positioned to help hospitals meet their infection control objectives, reduce their antibiotic usage and combat AMR in what is expected to be a multibillion-dollar market. Our commercial efforts are benefitting from the growing support for pre-surgical nasal decolonisation by leading organisations, as well as our real-world clinical successes in Canadian hospitals and adoption in other approved territories. While we are currently focused on nasal decolonisation to prevent healthcare-associate | purple11 | |
03/5/2024 08:10 | in today @6p | purple11 | |
03/5/2024 08:06 | Bought this morning | premium beeks | |
01/5/2024 13:39 | not a very nice fellow is he? how many times has he exited on his ramps leaving others to hold the baby? nasty bit of work and a terrible stock picker. READER BEWARE | purple11 | |
01/5/2024 12:10 | Read the thread i sold out at a profit and waiting to buy again. Now go f#ck yourself. WOW the thicko is a bellend | z1co | |
01/5/2024 11:44 | ZICO THE CLOWN strikes again halved since his buy in tip it really is pot luck with this guy.His losers seem to far outweigh his odd winner READER BEWARE | purple11 | |
26/4/2024 15:42 | OND does in fact face competion, e.g Destiny's XF-73 is equaly effective, also immune to the issue of resistance, and doesn't require a machine to activate it. Still, if I waa surgeon I might prefer OND's approach just because you can be 100% sure of compliance, though as a patient I would probably prefer XF-73. When it comes to outpatient treatments for the prevention or treatment of infected wounds/ulcers etc which both companies are targetting in the more distant future, Destiny's products would appear to address a much larger market because, they can be applied outside a clinical setting, e.g at home, horses for courses. | banshee | |
26/4/2024 11:23 | "You should know that I have spent much of last year on my back ith a femur in shards screwed back together waiting for the bone to regrow. How could you know much sbout preaching from time spent behind bars?" Now how would I know that? I left you at CPX with your tail between your legs Wish u a full recovery, health is wealth | jailbird | |
26/4/2024 11:08 | apologies to others for duplex post | scrutable | |
26/4/2024 11:07 | jailbird You should know that I have spent much of last year on my back with a femur in shards screwed back together waiting for the bone to regrow. How could you know much sbout preaching from time spent behind bars? The Bishop from the cathedral opposite my bedroom wundow in Exeter would never offer you his pulpit. It must be obvious to you, even though you are probably no longer in Clink why I am excited by photo disinfecton. | scrutable |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions